KRISTIE THUSS-TRUMAN: Open Payments
NPI 1003846080 · ALMA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$693 in 40 payments from 8 companies in 2025. Trend: 2023 $341 · 2024 $461 · 2025 $693
Food & beverage: $693
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 12 | $216 |
| Biogen, Inc. | 13 | $199 |
| Eisai Inc. | 9 | $152 |
| ABBVIE INC. | 2 | $47 |
| Novartis Pharmaceuticals Corporation | 1 | $27 |
| TG Therapeutics, Inc. | 1 | $20 |
| GENZYME CORPORATION | 1 | $18 |
| PFIZER INC. | 1 | $14 |
Products named: TYSABRI, Leqembi, Ocrevus, Ocrevus Zunovo, QULIPTA, KESIMPTA, BRIUMVI, NURTEC ODT.
Industry payments across MI — which companies pay providers there.
